| Wednesday | ||||
EF Hutton analyst Fozia… Story temporarily locked. | ||||
| Over a month ago | ||||
Maxim acted as sole book… Maxim acted as sole book running manager for the offering. | ||||
Maxim lowered the… Maxim lowered the firm's price target on Trxade Health to $1.75 from $2.50 and keeps a Buy rating on the shares. Trxade's results highlight the health in TRxADE Platform and improved margins in TRxADE Prime, the analyst tells investors in a research note. | ||||
Oragenics (OGEN)… Oragenics (OGEN) announced the appointment of Janet Huffman as CFO, effective March 7. Huffman is a financial executive with more than a dozen years of leadership experience at publicly traded and private healthcare companies. Huffman served as CFO for Trxade Health (MEDS), a Nasdaq-listed company focused on health services IT for retail pharmacies. | ||||
| Over a quarter ago | ||||
TRxADE HEALTH announced… TRxADE HEALTH announced that Bonum Health, a Digital Healthcare business subsidiary, has signed a preferred telemedicine services agreement with an independent group purchasing organization which will provide deep discounts to access Bonum Health's service platform for 100+ pharmacies and their patient's in the northeastern part of the United States. | ||||
Reports Q3 revenue $2.4M,… Reports Q3 revenue $2.4M, consensus $3.3M. | ||||
TRxADE HEALTH announced… TRxADE HEALTH announced that Bonum Health, a Digital Healthcare business subsidiary, has struck a strategic services distribution agreement with multiple insurance brokerage firms to offer access to telemedicine services for small to medium employer groups. The Company, which offers nationwide telemedicine services in all 50 states for humans and in select states for pets, will now work with insurance brokers to offer its telemedicine services to employer groups ranging from small-to-medium sized businesses. Suren Ajjarapu, Chairman and Chief Executive Officer of TRxADE added, "The Company maintains a strong commitment to diversifying its service offerings by establishing alternate distribution channels to promote our first-class telemedicine services. We plan to attempt to leverage these types of channels to promote our premier telemedicine services and grow Bonum Health's operations. We believe employers are looking for value-based services and need to create competitive benefit packages to attract and retain employees, as they navigate the day-to-day challenges that accompany a shrinking labor market, and high employee turnover. Employees will be bulk onboarded onto the telemedicine platform with full access to services as part of our Software-as-a-Service subscription business model." | ||||
TRxADE HEALTH… TRxADE HEALTH "announced that it has entered into a securities purchase agreement with a single institutional investor to purchase approximately $1.8M of its common stock in a registered direct offering and warrants to purchase common stock in a concurrent private placement. The combined effective purchase price for one share of common stock and associated warrants will be $1.15. Under the terms of the securities purchase agreement, TRxADE has agreed to sell 1,521,740 shares of common stock. In a private placement, which will be consummated concurrently with the offering, TRxADE also has agreed to issue warrants to purchase up to an aggregate of 2,663,045 shares of common stock. The warrants will be exercisable upon receipt of shareholder approval of the offering, will expire 5 years from the date of such shareholder approval and will have an exercise price of $1.50 per share of common stock. Maxim Group LLC is acting as the sole placement agent for the offering." | ||||
TRxADE HEALTH announced… TRxADE HEALTH announced the appointment of Jeff Newell to the Company's Board of Directors. Prior to his appointment to the Board of Directors, Newell served on the Company's Advisory Board. Newell will serve as a strategic resource to TRxADE as it continues to develop its trade relationships in the industry. | ||||
